Blood glucose monitors are growing up, and it's about time. With some 26 million diabetics in the U.S. alone, (that's almost 1 in 10 Americans), and hundreds of millions globally, according to the American Diabetes Association, glucose monitoring has become one of the largest patient-generated data sets in the world -- and yet much of that data is being uploaded manually onto desktops or written by hand into little log books.
Most vaccines work by giving the immune system a crash course in how to attack bacteria or viruses. The goal is to protect against diseases -- think influenza, polio, and smallpox, which have collectively killed tens of millions of people in recent history.
Now an experimental vaccine being developed at Stanford University uses an entirely different approach to get at the same end goal -- protecting against type 1 diabetes by instructing a diabetic's immune system to stop attacking its own body.… Read more
For diabetics who have to constantly manage their blood-sugar levels, insulin works. The problem is, many people with Type 1 diabetes have to prick their fingers multiple times a day to monitor their levels, and inject themselves with insulin when those levels are too high. And they don't always administer the right amount at the right time.
Researchers at the Massachusetts Institute of Technology and Boston Children's Hospital hope to automate insulin delivery with a novel nanotech approach that involves injecting a gel that detects blood-sugar levels and secretes insulin when needed -- with a single injection doing do the trick for as many as 10 days.… Read more
Insulin pumps, which deliver fast-acting insulin continuously through a catheter and are often preferred over injections, are still only used by only 20 to 30 percent of the 1.5 million people in the U.S. who are diagnosed with Type I diabetes.
Pumps might start getting more popular as the systems are get smaller, sleeker, and easier to use. Take Tandem Diabetes Care's t:slim, an insulin delivery system that has just been cleared by the FDA.
It's not only the smallest, but also the first to employ touch screen technology. Friends just might get gadget envy.… Read more
A security researcher who has proven he can remotely disable the insulin pump he relies on to keep his diabetes in check says the device maker is refusing to acknowledge the problem and misleading the public.
However, Medtronic, the maker of the insulin pump in question and one of the largest medical device manufacturers in the world, insists that the risk is very low.
Other insulin pumps allow for software updates, but to plug any holes in the software of the Medtronic pump would require a recall of all the devices now in use by patients--a costly endeavor and potentially … Read more
Two members of the U.S. Congress are asking government auditors to investigate the security risks of wireless medical devices, after they learned of a security researcher who found he could remotely control his own insulin pump and blood-sugar monitor.
Representatives Anna G. Eshoo, a California Democrat, and Edward Markey, a Democrat from Massachusetts, senior members of the House Energy and Commerce Committee, sent a letter to the Government Accountability Office earlier this week asking the GAO to examine whether the Federal Communications Commission is ensuring that new medical devices and implants that use wireless technology can't be tampered … Read more